[1]
J. Jose, M. George, and L. Joseph, “A REVIEW ON THE EFFECT OF FEBUXOSTAT IN CHRONIC KIDNEY PATIENTS, IT’S SIGNIFICANCE IN eGFR, URIC ACID AND ALBUMINURIA.”, IJPBA, vol. 7, no. 2, Apr. 2019.